Selective serotonin receptor inverse agonists as therapeutics for disease

Details for Australian Patent Application No. 2005244982 (hide)

Owner Acadia Pharmaceuticals Inc.

Inventors Weiner, David M.; Davis, Robert E.; Brann, Mark R.

Agent Spruson & Ferguson

Pub. Number AU-B-2005244982

PCT Pub. Number WO2005/112927

Priority 10/854,035 24.05.04 US; 10/850,819 21.05.04 US

Filing date 20 May 2005

Wipo publication date 1 December 2005

Acceptance publication date 27 January 2011

International Classifications

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/112927 Priority application(s): WO2005/112927

27 January 2011 Application Accepted

  Published as AU-B-2005244982

26 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244985-Acyclovir formulations

2005244980-Chemical linkers and conjugates thereof